RYGHT FOR CROs

Lower Costs, Faster Enrollment, Happier Sponsors

Use Ryght's AI Digital Twin platform to secure your competitive edge, bring life-changing therapies to patients sooner, and achieve unparalleled cost efficiencies.

Ryght AI Clinical Trial Software for CROs
SCALE OPERATIONS WITHOUT SCALING HEADCOUNT

Reduce operational costs & resources

Ryght AI's platform allows your existing team to manage larger portfolios while increasing quality, enabling your existing team to manage larger portfolios while increasing value, improving your operational efficiency and profit margins.

ELIMINATE DATABASE SUBSCRIPTIONS AND MANUAL LABOR COSTS

Cut months of manual research down to minutes. Our AI-powered platform instantly analyzes the protocol and scans 100,000 AI digital twins to identify optimal sites, eliminating the need for expensive data subscriptions and costly consultants.

ACCELERATE FEASIBILITY RESPONSE TIMES

Pre-populated feasibility questionnaires based on AI twin data mean sites only need to review and confirm answers instead of starting from scratch. This reduces traditional 4-6 week feasibility cycles to just days, freeing up your team for higher-value activities.

MINIMIZE SITE SELECTION ERRORS

Advanced AI matching eliminates costly site selection mistakes that lead to poor enrollment, protocol deviations, and study delays. Our precision matching reduces the risk of selecting underperforming sites that drain resources throughout the study lifecycle.

REDUCE TRAVEL & DUE DILIGENCE COSTS

Our comprehensive digital twins provide deep insights into site capabilities before you invest in costly site visits and extensive due diligence processes, allowing you to focus resources only on the most promising candidates.

GAIN A COMPETITIVE EDGE

Deliver exceptional value to your clients

Differentiate your CRO with cutting-edge technology that delivers measurably better outcomes. Demonstrate clear ROI to your clients through faster timelines, reduced costs, and improved study success rates that keep customers coming back.

GET TO MARKET SOONER

Compress traditional 6-12 month site identification and selection timelines into weeks. Your sponsors can advance their programs to market faster, translating saved time into millions of dollars in extended market exclusivity.

SUPERIOR SITE QUALITY & PERFORMANCE

Our AI matching ensures optimal alignment between protocol requirements and site capabilities, leading to higher enrollment rates, better protocol compliance, and reduced study risk for your biopharma clients.

GLOBAL REACH WITH LOCAL EXPERTISE

Gaining access to AI digital twins of 100,000 clinical research sites across the globe means you can confidently take on international studies and help clients expand into new markets without the traditional barriers of local knowledge and network limitations.

POWERFUL SOLUTIONS

Explore the Ryght platform

RYGHT AI Platform for CROs
NETWORK NAVIGATOR

Leverage AI-powered digital twins to instantly analyze every research site around the globe and reveal the locations that best match your protocol’s needs. 

LEARN MORE
Ryght AI Feasibility Accelerator
FEASIBILITY ACCELERATOR

Automatically send qualified sites pre-populated feasibility questionnaires powered by data from our AI digital twin network. Track and compare all responses in real-time.

LEARN MORE

Available on the Microsoft Azure Marketplace

Ryght is available on Microsoft Azure Marketplace, making it easy for sponsors and CROs to use existing cloud commitments, simplify billing, and increase cost efficiency.

Screenshot 2025-07-21 at 12.21.22 PM
PUT RYGHT TO THE TEST

Discover the difference AI-powered site selection and feasibility can make.

Experience Ryght’s impact firsthand. Share a previous protocol with us—within twenty minutes, you’ll see how effortlessly Ryght identifies top trial sites faster (and more accurately) than your current methods. 

 

Test Ryght on an old protocol to see how we stack up.

Related resources

KEEP UP WITH RYGHT

Stay connected

Subscribe to be the first to know about product updates, news and announcements.